Cargando…
Drug resistance genomics of the antimalarial drug artemisinin
Across the globe, over 200 million annual malaria infections result in up to 660,000 deaths, 77% of which occur in children under the age of five years. Although prevention is important, malaria deaths are typically prevented by using antimalarial drugs that eliminate symptoms and clear parasites fr...
Autores principales: | Winzeler, Elizabeth A, Manary, Micah J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283579/ https://www.ncbi.nlm.nih.gov/pubmed/25470531 http://dx.doi.org/10.1186/s13059-014-0544-6 |
Ejemplares similares
-
The genomic architecture of antimalarial drug resistance
por: Cowell, Annie N, et al.
Publicado: (2019) -
Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance
por: Heller, Laura E., et al.
Publicado: (2019) -
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023) -
Exploration of the Plasmodium falciparum Resistome and Druggable Genome Reveals New Mechanisms of Drug Resistance and Antimalarial Targets
por: Cowell, Annie, et al.
Publicado: (2018) -
Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)